Science & Research

The Maryland University of Integrative Health is officially the second university in the state to launch a graduate program in cannabis science.

A recent study investigating potential treatments for the deadly symptoms of COVID-19 reports that 100% of lab mice who received injections of THC survived the frequently fatal immune system response to the virus.

A recent investigation of rolling paper products found that 90% contained some quantity of heavy metals, with 8 percent testing higher than “the allowable limits” under California’s cannabis rules.

The United States spent $1.49 billion on cannabis research between 2000 and 2018. Most of the funds were directed at understanding the potential harms of cannabis use.

Zookeepers at Poland’s Warsaw Zoo have announced a new project testing whether CBD oil can help to reduce symptoms of anxiety and depression in elephants.

A study by the University of Vermont found that the majority of medical cannabis patients in the state do not believe that their primary care doctor is a reliable source of info about medical cannabis.

A recent study by San Diego State University shows that after-hours cannabis use by employees has no negative effects on workplace performance.

Most cannabis consumers agree that the legal cannabis industry is more convenient and provides safer purchases than its unregulated counterpart.

A recent study by the Ottowa Hospital in Ontario, Canada suggests that cannabis use during pregnancy can increase the risk of autism.

MAPS, the Multidisciplinary Association of Psychedelic Studies, issued a public response to the DEA’s repeatedly delayed licensing of additional research-grade cannabis growers.

The University of Pittsburgh has announced a 10-year research program with medical cannabis company Parallel (formerly Surterra Wellness).

A first-of-its-kind study published last month suggests that women who use cannabis on a regular basis experience higher rates of sexual satisfaction.

New research by Israeli firms Eybna and CannaSoul Analytics suggests that a combination of CBD and terpenes might be effective against the deadly cytokine storms that are symptomatic of COVID-19.

The FDA has opened public comments for new preliminary guidance from the agency for cannabis pharmaceutical research.

New research from the University of California, Irvine has determined that cannabis is a safe and potentially effective treatment for the chronic pain associated with sickle cell disease.

A recent investigation from the Routledge Handbook of Interdisciplinary Cannabis Research exposes the harsh reality of indoor cannabis cultivation’s negative environmental impact.

Lawmakers in the House of Representatives have advanced a highways infrastructure bill that includes language making products from state-legal cannabis markets available for federal research purposes.

Canadian researchers suggest that certain cannabinoid extractions could help to quell an immune system response to the coronavirus that has proven fatal in some patients; the study was published as a pre-print, meaning it has not been peer-reviewed.

FSD Pharma has received FDA permission to design and submit an application for a new trial using a synthetic cannabinoid-based drug in the treatment of COVID-19.

A recent industry analysis found that Leafs By Snoop is the most recognizable cannabis brand, followed by Cheeba Chews and Marley Natural.

A recent study published in the journal Pain found that CBD treatment for dogs with osteoarthritis was beneficial in 9 out of 10 cases.

Researchers have identified a material found on altars at the entrance of an ancient Judahite shrine as cannabis; experts say the cannabis was likely used for its mind-altering effects.

A recent study suggests that female cannabis users experience more intense cannabis cravings than their male counterparts.

A recent study published in Frontiers in Psychology suggests there is no evidence suggesting that just prenatal cannabis exposure can lead to significant cognitive impairments.